Youcare Pharmaceutical Group Co Ltd
SSE:688658
Youcare Pharmaceutical Group Co Ltd
SSE:688658
Price:
16.3
CNY
-8.94%
Market Closed
Market Cap:
¥7.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Youcare Pharmaceutical Group Co Ltd
SSE:688658
|
CN |
|
A
|
Axis Auto Finance Inc
XTSX:AXIS
|
CA |
|
Janus Henderson Group PLC
NYSE:JHG
|
UK |
|
Asbury Automotive Group Inc
NYSE:ABG
|
US |
|
Kite Realty Group Trust
NYSE:KRG
|
US |
|
Plastiblends India Ltd
NSE:PLASTIBLEN
|
IN |
|
NextSource Materials Inc
TSX:NEXT
|
CA |
|
Aspen Aerogels Inc
NYSE:ASPN
|
US |
|
S
|
Sonic Interfreight PCL
SET:SONIC
|
TH |
|
Hornby PLC
LSE:HRN
|
UK |
|
F
|
Finnair Oyj
OMXH:FIA1S
|
FI |
Relative Value
The Relative Value of one
Youcare Pharmaceutical Group Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 16.3 CNY,
Youcare Pharmaceutical Group Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Youcare Pharmaceutical Group Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Youcare Pharmaceutical Group Co Ltd Competitors
Youcare Pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Youcare Pharmaceutical Group Co Ltd
SSE:688658
|
7.3B CNY | 2.9 | -31.3 | -24.8 | -24.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.2 | 41.7 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 27.9 | 15.5 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.5 | 12.7 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.3 | 6.9 | 8.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
